RCM
PEARW

Rivernorth Capital Management’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

Rivernorth Capital Management’s Portfolio PEARW Stock Details PEARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-42,089
Closed -$25K – 883
2021
Q4 		$25K Hold
42,089
– – ﹤0.01% 634
2021
Q3 		$40K Buy
+42,089
New +$43.9K ﹤0.01% 471

Other funds holding PEARW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
KCM
Kingstown Capital Management New York $30.4M AUM 3.71% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Rivernorth Capital Management's PEARW Position: Q1 2022 in Review

Rivernorth Capital Management sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q1 2022, closing a stake of 42,089 shares — an estimated $25K sold.

Rivernorth Capital Management first reported a position in PEARW in Q3 2021 and held it in 2 quarters. The position peaked at $40K in Q3 2021. 40 funds tracked by Wall St. Rank hold PEARW as of Q1 2022.

  • Rivernorth Capital Management reported no remaining Pear Therapeutics, Inc. Warrant position as of Q1 2022 after selling out during the quarter.
  • Rivernorth Capital Management sold 42,089 Pear Therapeutics, Inc. Warrant shares in Q1 2022, an estimated $25K.
  • Rivernorth Capital Management first reported a position in Pear Therapeutics, Inc. Warrant in Q3 2021 and held it in 2 quarters.
  • Rivernorth Capital Management's Pear Therapeutics, Inc. Warrant position peaked at $40K in Q3 2021.
  • 40 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q1 2022.

Based on Rivernorth Capital Management's 13F filing for Q1 2022, filed 16 May 2022.